Obstetrics & Gynaecology · Cervical Carcinoma (Risk Factors, Staging, Treatment)

The GOG 120 trial established concurrent cisplatin-based chemoradiation as superior to radiation alone for cervical cancer. Which regimen was NOT included in GOG 120?

  • A Weekly cisplatin 40 mg/m²
  • B Hydroxyurea
  • C Carboplatin + paclitaxel
  • D Cisplatin + 5-FU + hydroxyurea
Correct answer: C. Carboplatin + paclitaxel

Explanation

GOG 120 compared three arms: (1) weekly cisplatin 40 mg/m², (2) hydroxyurea alone, and (3) cisplatin + 5-FU + hydroxyurea — all with pelvic radiation. Weekly cisplatin and the triple-drug arm both outperformed hydroxyurea alone, establishing concurrent cisplatin as the standard. Carboplatin + paclitaxel was not part of GOG 120; this doublet is used in recurrent/metastatic cervical cancer (GOG 240 added bevacizumab to this backbone).

Reference: Shaw's Textbook of Gynaecology, 17th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Cervical Carcinoma (Risk Factors, Staging, Treatment) MCQs

See all Cervical Carcinoma (Risk Factors, Staging, Treatment) MCQs →